Atlanta biologicals, INC. [12-005007]

Ended Awarded

Contract number
HHSN26100004
Awardee
Awarding agency
Obligated
$4,959

Award facts

Contract value 100% obligated
$4,958.78 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lawrenceville, GA 30043, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Atlanta Biologicals Incorporated, a commercial vendor, on October 24, 2011. The contract, valued at $4,958.78, has a completion date of November 30, 2011 and does not have a set-aside designation. This contract was awarded under a larger contracting vehicle, but no further details about the vehicle are provided. The contract is for the provision of unspecified products or services to the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services.

Quick answers

Who was awarded contract HHSN26100004?

HHSN26100004 was awarded to Atlanta Biologicals Incorporated by National Cancer Institute (National Institutes of Health) on October 24, 2011.

How much is contract HHSN26100004 worth?

The government has obligated $4,959 on HHSN26100004.

Is contract HHSN26100004 an order under another contract?

Yes. HHSN26100004 is a BPA call under HHSN263200600063475B, a blanket purchase agreement.

Was contract HHSN26100004 competed?

The extent of competition for HHSN26100004 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award